Please login to the form below

Not currently logged in

Dr Holger Adelmann joins DIA EMEA

Succeeds Dr Jytte Lynvig as senior vice president and managing director

Dr Holger AdelmannThe DIA (Drug Information Association) has appointed Dr Holger Adelmann as its new senior vice president and managing director for DIA Europe, Middle East and Africa (EMEA).

Dr Adelmann brings nearly 30 years of clinical pharmacology experience to the role at the Washington, DC-headquartered group.

He joined the industry in 1989 and has previously held leading positions at AstraZeneca, Bayer, Merk Serono and Tropon.

Most recently, Dr Adelmann served as the global head of Merck Serono's clinical pharmacology and clinical biomarker operations in Germany.

In that role he oversaw the reengineering of its clinical biomarker and companion diagnostics business to align with upcoming portfolio demands.

Barbara Lopez Kunz, DIA's global chief executive, said: “Holger's diverse background provides us with the leadership necessary to deliver that trusted, future-oriented knowledge and connect the global health care community to this rapidly evolving region.”

Dr Adlemann succeeds Dr Jytte Lynvig who retired from the post earlier this month.

22nd February 2016

From: Sales



Featured jobs

Subscribe to our email news alerts


Add my company
VCCP Health

We’re the challenger agency for challenger brands. Brands with a point to prove. Rx, OTC and wellness brands run by...

Latest intelligence

When is it time to rebrand?
The Biosimilar Challenge
How health behaviours and clinical outcomes are related
When HCPs understand patient activation levels they can actively guide patients towards more confident self-management of diverse health concerns....